Phospho-LCK (S540) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide.
Form
Liquid
Lead Time
Product dispatch typically occurs within 1-3 business days of order receipt. Delivery times may vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Synonyms
IMD22 antibody; LCK antibody; Lck p56 antibody; LCK proto-oncogene; Src family tyrosine kinase antibody; LCK_HUMAN antibody; Leukocyte C-terminal Src kinase antibody; LSK antibody; Lymphocyte cell specific protein tyrosine kinase antibody; Lymphocyte cell-specific protein-tyrosine kinase antibody; Lymphocyte specific protein tyrosine kinase antibody; Membrane associated protein tyrosine kinase antibody; Oncogene lck antibody; P56 LCK antibody; p56(LSTRA) protein tyrosine kinase antibody; p56-LCK antibody; p56lck antibody; pp58 lck antibody; pp58lck antibody; Protein YT16 antibody; Proto oncogene tyrosine protein kinase LCK antibody; Proto-oncogene Lck antibody; Protooncogene tyrosine protein kinase LCK antibody; T cell specific protein tyrosine kinase antibody; T cell-specific protein-tyrosine kinase antibody; T lymphocyte specific protein tyrosine kinase p56lck antibody; Tyrosine-protein kinase Lck antibody; YT 16 antibody; YT16 antibody
Target Names
LCK
Uniprot No.

Target Background

Function

Phospho-LCK (Ser540) antibody targets LCK, a non-receptor tyrosine-protein kinase crucial for T-cell development and function. LCK plays a vital role in T-cell antigen receptor (TCR)-mediated signal transduction. It is constitutively associated with the cytoplasmic domains of CD4 and CD8 surface receptors. TCR engagement with peptide-MHC complexes facilitates CD4/CD8 interaction with MHC molecules, recruiting LCK to the TCR/CD3 complex. Subsequently, LCK phosphorylates immunoreceptor tyrosine-based activation motifs (ITAMs) within the cytoplasmic tails of TCR-γ chains and CD3 subunits, initiating TCR/CD3 signaling. This triggers ZAP70 recruitment, phosphorylation, and activation by LCK, leading to downstream signaling events, ultimately resulting in lymphokine production. LCK also contributes to signaling pathways involving other receptors, notably CD2 and the IL2 receptor. Its expression persists throughout thymocyte development, regulating maturation processes governed by both pre-TCR and mature αβ TCR. Known substrates of LCK phosphorylation include RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH, and TYROBP. LCK also interacts with FYB2.

Gene References Into Functions

Numerous studies highlight the diverse roles of LCK in T-cell signaling and beyond. Key findings include:

  • The ionic CD3-ε-Lck interaction regulates T-cell receptor phosphorylation (PMID: 28659468).
  • PLC-γ1 positively regulates Zap-70 and TCR tyrosine phosphorylation but negatively regulates SLP-76-associated protein phosphorylation (PMID: 28644030).
  • Lck autophosphorylation is essential for its catalytic activity, and its activity is enhanced by CD4 and CD8 coreceptors (PMID: 29083415).
  • The IL-2-R/Lck/PLCγ/PKCθ/αPIX/Rac1/PYGM signaling pathway controls T-cell migration and proliferation (PMID: 27519475).
  • Aurora-A regulates Lck activity during T-cell activation (PMID: 27910998).
  • CD28 cytoplasmic domain mutations reduce PKCθ recruitment to the CD28-Lck complex (PMID: 27460989).
  • Phosphorylation of Tyr(394) plays a significant role in Lck function (PMID: 28096507).
  • WASH regulates NK cell cytotoxicity via Lck-mediated Y141 tyrosine phosphorylation (PMID: 27441653).
  • A phosphosite within the Lck SH2 domain regulates its activation by CD45, forming a negative feedback loop (PMID: 28735895).
  • A novel LCK splicing mutation is associated with HPV infection progression (PMID: 27087313).
  • Lck serves as a major signaling hub of CD147 in T cells (PMID: 28148733).
  • HSP65 suppresses cholesterol efflux via an Lck-mediated pathway (PMID: 27742830).
  • LSKlow cells from p18(-/-) mice exhibit lymphoid differentiation and repopulation capabilities (PMID: 27287689).
  • PM lipids modulate Lck interaction with its binding partners via its SH2 domain (PMID: 27334919).
  • Lck is critical for Toll-like receptor signal transduction in T cells (PMID: 26888964).
  • Aurora A maintains Lck activity during T-cell activation (PMID: 27091106).
  • Lck represses oxidative phosphorylation via kinase-independent binding with mitochondrial CRIF1 (PMID: 26210498).
  • CD4's Lck-independent role in T-cell activation is impaired by mutations within its binding patch (PMID: 26147390).
  • Nuclear Lck promotes human leukemic T-cell survival via interaction with CRIF1 (PMID: 25997448).
  • TSAD enhances Nck-Lck and Nck-SLP-76 interaction in T cells (PMID: 26163016).
  • Dynamic Lck palmitoylation is essential for Fas receptor signaling (PMID: 26351666).
  • PAX5 translocation patients exhibit LCK upregulation and STAT5 hyperphosphorylation (PMID: 25595912).
  • TCR-CD3 complex and Lck are required for Ca(2+) mobilization but not apoptosis in Jurkat cells (PMID: 25947381).
  • Cholesterol-dependent domains regulate Lck activity by sequestering it from CD45 (PMID: 25658353).
  • CD45 both positively and negatively regulates TCR phosphorylation depending on Lck activity (PMID: 25128530).
  • CD222 deficiency impairs Lck recruitment to CD45 (PMID: 25127865).
  • Lck mediates signal transmission from CD59 to the TCR/CD3 pathway (PMID: 24454946).
  • NUP214-ABL1-mediated proliferation depends on Lck and interacting proteins (PMID: 23872305).
  • Lck phosphorylates Tyr-342 of FOXP3, affecting MMP9 expression (PMID: 24155921).
  • SAP forms a signaling complex with NTB-A and Lck to potentiate restimulation-induced T-cell death (PMID: 24688028).
  • Lck plays a major role in BCR-mediated signaling in CLL cells (PMID: 23505068).
  • Nef interferes with Lck plasma membrane delivery (PMID: 23601552).
  • FAK deficiency impairs inhibitory Lck phosphorylation (PMID: 24227778).
  • Spatial regulation of Lck by CD45 and GM1 ganglioside determines the apoptotic response to Gal-1 (PMID: 24231767).
  • VP11/12 SFK-binding motifs recruit Lck, leading to downstream phosphorylation events (PMID: 23946459).
  • LCK plays a crucial role in T-cell activation signal transduction (PMID: 23931554).
  • Conformational states regulate clustering in early T-cell signaling (PMID: 23202272).
  • TCR stimulation leads to phosphorylation of p56(lck) residues (PMID: 22674786).
  • LCK-positive tumor infiltrate is associated with longer survival in NSCLC patients (PMID: 22457183).
  • Cytoskeletal modulation of lipid interactions regulates Lck activity (PMID: 22613726).
  • Ca(2+) increases induce CaMKII activation and Lck-dependent p66Shc phosphorylation, promoting apoptosis (PMID: 21983898).
  • The Kv1.3/Dlg1/Lck complex regulates T-cell function via cAMP (PMID: 22378744).
  • DHHC2 is involved in Lck S-acylation (PMID: 22034844).
  • Residues 112-126 of human LAT are required for its interaction with Lck (PMID: 22034845).
  • Feedback circuits regulate basal Lck-dependent events in TCR signaling (PMID: 21917715).
  • MG132-induced apoptosis is enhanced by p56(lck) through ER stress (PMID: 21819973).
  • MAL regulates membrane order and protein sorting of Lck and LAT (PMID: 21508261).
  • Deregulations of Lck-ZAP-70-Cbl-b and miR181a are associated with leprosy progression (PMID: 21453975).
  • Preactivated Lck is necessary and sufficient for T-cell activation independently of the TCR in the absence of antigen (PMID: 21266711).
  • SOCS1 interacts with oncogenic Lck (PMID: 21234523).
Database Links

HGNC: 6524

OMIM: 153390

KEGG: hsa:3932

STRING: 9606.ENSP00000337825

UniGene: Hs.470627

Involvement In Disease
Immunodeficiency 22 (IMD22)
Protein Families
Protein kinase superfamily, Tyr protein kinase family, SRC subfamily
Subcellular Location
Cell membrane; Lipid-anchor; Cytoplasmic side. Cytoplasm, cytosol.
Tissue Specificity
Expressed specifically in lymphoid cells.

Q&A

What is LCK and what role does S540 phosphorylation play in T cell signaling?

LCK (Lymphocyte-specific protein tyrosine kinase) is essential for T-lymphocyte activation and differentiation, serving as a critical upstream kinase in T cell receptor (TCR) signaling . While phosphorylation at Tyr505 downregulates LCK's catalytic activity and phosphorylation at Tyr394 increases its activity , the S540 phosphorylation represents an additional regulatory site that contributes to fine-tuning LCK function in TCR signaling cascades . Understanding S540 phosphorylation provides additional insight into the complex regulation of this crucial signaling protein.

How does Phospho-LCK (S540) antibody differ from other LCK phosphorylation site antibodies?

The Phospho-LCK (S540) antibody specifically recognizes LCK when phosphorylated at serine residue 540, unlike antibodies targeting phosphorylation at Tyr505 or Tyr394 . This specificity allows researchers to distinguish between different regulatory states of LCK. For example, Phospho-LCK (Y505) antibodies detect the inhibitory phosphorylation site, whereas the S540 antibody recognizes a distinct regulatory modification, enabling more comprehensive analysis of LCK's phosphorylation status during T cell activation .

What are the validated applications for Phospho-LCK (S540) antibody?

According to available data, Phospho-LCK (S540) antibody has been validated for:

ApplicationDilutionReference
Western Blotting1:500-1:2000
ELISA1:40000

While these applications have been validated, researchers should perform their own optimization for specific experimental conditions. The antibody may potentially be useful for other applications such as immunohistochemistry or flow cytometry, though additional validation would be required .

What are the optimal conditions for using Phospho-LCK (S540) antibody in Western blotting experiments?

For optimal Western blotting results with Phospho-LCK (S540) antibody:

  • Use dilutions between 1:500 and 1:2000 as recommended

  • Prepare samples in appropriate lysis buffer containing phosphatase inhibitors (e.g., sodium orthovanadate) to preserve phosphorylation status

  • Run samples under reducing conditions on SDS-PAGE gels

  • Transfer to PVDF or nitrocellulose membranes

  • Block with 5% BSA in TBST rather than milk, as milk contains phosphoproteins that may interfere with detection

  • Incubate with primary antibody overnight at 4°C for optimal binding

  • Use appropriate HRP-conjugated secondary antibodies (anti-rabbit IgG for polyclonal antibodies)

For comparison, protocols for other phospho-specific LCK antibodies involve similar approaches but may require different dilutions (e.g., Phospho-Lck Y505 is typically used at 1:1000) .

How can I optimize T cell stimulation to study S540 phosphorylation dynamics?

To effectively study S540 phosphorylation dynamics:

  • For in vitro T cell activation, consider these evidence-based approaches:

    • Anti-CD3ε antibody stimulation (5 μg/mL at 37°C)

    • Pervanadate treatment (1 mM for 10 minutes) to inhibit phosphatases

    • H₂O₂ treatment (2 mM for 2 minutes) to modulate redox-sensitive phosphorylation

    • Superantigen stimulation (e.g., SEE at 30 ng/mL)

  • Include appropriate time points (typically 1-30 minutes) to capture phosphorylation kinetics

  • Lyse cells in buffer containing phosphatase inhibitors (4 mM NaVO₃, 40 mM NaF) to preserve phosphorylation status

  • Consider parallel assessment of multiple phosphorylation sites (Y505, Y394, S540) to understand their interrelationships

What controls should I include when working with Phospho-LCK (S540) antibody?

Robust experimental design requires appropriate controls:

  • Positive controls: Jurkat T cells stimulated with pervanadate or H₂O₂ show detectable LCK phosphorylation

  • Negative controls:

    • Unstimulated T cells (resting state)

    • Samples treated with phosphatase

    • Isotype control antibody to assess non-specific binding

  • Specificity controls:

    • Blocking peptide competition assay using the immunizing peptide

    • siRNA knockdown of LCK to confirm band specificity

    • Comparing reactivity across species (human, mouse, rat) as specified in product information

  • Loading controls: β-actin or other housekeeping proteins to normalize protein loading

How can I use Phospho-LCK (S540) antibody to distinguish between different T cell activation states?

Advanced experimental approaches include:

  • Temporal analysis: Monitor S540 phosphorylation alongside Y505 and Y394 phosphorylation during T cell activation to create a phosphorylation signature profile specific to different T cell stimuli

  • Stimulus comparison:

    • Compare TCR-mediated versus cytokine-mediated phosphorylation patterns

    • Analyze differences between strong TCR stimulation (which induces transient calcium elevation) versus weak stimulation (which generates sustained calcium oscillations)

  • Single-cell analysis:

    • Combine phospho-flow cytometry with other cellular markers to identify cell subpopulations with distinct phosphorylation profiles

    • Correlate with functional outcomes (e.g., cytokine production, proliferation)

  • High-throughput methodologies:

    • Combine with peptide library screens similar to those described for other phosphorylation sites to identify substrate preferences

    • Integrate with proteomics approaches to map complex signaling networks

How can molecular dynamics simulations enhance our understanding of LCK S540 phosphorylation?

Molecular dynamics approaches can reveal crucial mechanistic insights:

  • Similar to methods described for other LCK phosphorylation sites, researchers can conduct 500+ ns simulations of the LCK kinase domain with modeled S540 phosphorylation

  • Key simulation parameters based on published protocols:

    • Use crystal structures of LCK kinase domain in active conformation as starting coordinates

    • Model substrate peptides based on known LCK targets

    • Include ATP, Mg²⁺ ions, and water molecules in the active site

    • Cap polypeptide chains with N-acetyl and N-methylcarboxamide groups

  • Analyze simulations to determine:

    • Conformational changes induced by S540 phosphorylation

    • Potential electrostatic interactions affected by this modification

    • Influence on substrate binding and catalytic activity

  • Compare with simulations of other phosphorylation states (Y394, Y505) to develop a comprehensive model of LCK regulation

What are common challenges when working with Phospho-LCK (S540) antibody and how can they be addressed?

ChallengePotential Solution
Low signal in Western blottingIncrease antibody concentration within recommended range (1:500-1:2000); Optimize exposure time; Enhance phosphorylation using pervanadate treatment
High backgroundUse more stringent washing conditions; Optimize blocking (5% BSA recommended); Increase antibody dilution
Poor reproducibilityStandardize cell stimulation protocols; Use fresh phosphatase inhibitors; Maintain consistent sample handling
Cross-reactivity with other phosphoproteinsValidate specificity using blocking peptides or LCK knockdown; Consider immunoprecipitation before Western blotting
Degradation of phosphorylationProcess samples quickly; Keep samples cold; Use multiple phosphatase inhibitors (NaVO₃, NaF)

How does sample preparation affect Phospho-LCK (S540) detection?

Sample preparation is critical for preserving phosphorylation status:

  • Lysis buffer composition: Use buffers containing effective phosphatase inhibitor combinations. Published protocols recommend:

    • 2-4% NP40 or equivalent detergent

    • 50 mM Tris-HCl

    • 150 mM NaCl

    • 10 mM EDTA

    • 4 mM NaVO₃

    • 40 mM NaF (pH 7.4)

  • Temperature control: Maintain samples at 4°C during processing to minimize phosphatase activity

  • Timing considerations:

    • Process samples immediately after stimulation

    • For time-course experiments, use rapid sample quenching methods

    • Consider flash-freezing samples if immediate processing isn't possible

  • Storage conditions: Store antibody according to manufacturer recommendations (typically at -20°C or -80°C, avoid repeated freeze-thaw cycles)

How can I optimize detection of multiple LCK phosphorylation sites in a single experiment?

For comprehensive LCK phosphorylation analysis:

  • Sequential immunoblotting:

    • Strip and reprobe membranes with different phospho-specific antibodies

    • Carefully control stripping conditions to preserve epitopes

    • Consider running duplicate gels if multiple phospho-sites must be analyzed simultaneously

  • Multiplex flow cytometry:

    • Use differently conjugated secondary antibodies for each phospho-specific primary

    • Employ careful titration to prevent antibody interference

    • Validate specificity with appropriate controls

  • Imaging techniques:

    • For cellular localization studies, use appropriate fixation methods that preserve phospho-epitopes

    • Consider TIRF-SIM imaging for TCR clustering studies as described in the literature

    • Optimize immunofluorescence protocols for each phospho-antibody separately before attempting multiplex detection

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.